文献速递关节外科创伤骨科骨肿瘤

英国多中心队列研究:非肿瘤性疾病股骨远端置换的临床结局——非肿瘤性疾病内假体置换(EPRO)研究

A UK multicentre cohort study of clinical outcomes of distal femoral replacement for nononcological conditions : the EndoProsthetic Replacement for nonOncological conditions (EPRO) study.
PubMed 文献 · Bone Joint J · 2025-06-01

该多中心回顾性队列研究纳入英国五中心2009年8月1日至2023年4月1日间227例非肿瘤性疾病股骨远端置换,中位年龄78.2岁,中位随访3.9年。局部并发症率21%,再手术率16%,两年假体生存率80.9%(SE 2.8)。感染翻修、构建体与柄比增加及手术时间延长与失败风险升高相关(p<0.05)。作者认为因局部并发症和再手术率高,应将其视为复杂膝关节重建的挽救选项并对患者充分告知。

要点

  • 227例非肿瘤性股骨远端置换局部并发症率21%,再手术率16%。
  • 两年假体生存率80.9%(SE 2.8)。
  • 感染翻修、构建体与柄比增加及手术时间延长与失败风险升高相关(p<0.05)。

核心结论

  • 这是非肿瘤性疾病股骨远端置换的最大样本研究。
  • 由于局部并发症率和再手术率高,应将其视为复杂膝关节重建的挽救选项,并对患者进行充分告知。

研究设计与样本

  • 英国五中心多中心回顾性队列研究,纳入2009年8月1日至2023年4月1日间227例股骨远端置换,中位年龄78.2岁(IQR 70.1至84.0),中位随访3.9年(IQR 1.5至7.1)。
  • 适应证包括假体周围股骨骨折(n=74;33%)、无菌性翻修关节置换(n=45;20%)、急性创伤(n=42;19%)、感染性翻修关节置换(n=40;18%)、慢性/失败创伤(n=14;6%)和复杂初次关节置换(n=12;5%)。
  • 主要结局为局部并发症率;次要结局包括输血率、重症监护需求、恢复至基线活动能力和居住状态、全身并发症率、再手术率和死亡率;采用Kaplan-Meier法以局部并发症为终点进行假体生存分析,采用二元逻辑回归识别局部并发症危险因素。

主要发现

  • 局部并发症率为21%(48例),最常见的局部并发症为假体周围关节感染(n=22;10%)、假体周围股骨骨折(n=7;3%)和无菌性松动(n=7;3%)。
  • 57例(25%)需要输血,67例(30%)需要重症监护设施。
  • 恢复至基线活动能力和居住状态分别为94例(50%)和183例(83%)。
  • 六个月全身并发症率为12%(n=27),再手术率为16%(n=36);30天和一年死亡率分别为3%(n=6)和9%(n=21)。
  • 两年假体生存率为80.9%(SE 2.8)。

临床怎么用

  • 作者认为,由于局部并发症率和再手术率高,股骨远端置换应被视为复杂膝关节重建的挽救选项,并对患者进行充分告知。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: This study aims to determine the outcomes of distal femoral replacements (DFRs) for nononcological conditions. METHODS: This was a multicentre retrospective cohort study across five UK centres between 1 August 2009 and 1 April 2023. The primary outcome was the local complication rate. Secondary outcomes assessed were blood transfusion rate, critical care requirements, return to baseline mobility and residence status, systemic complication rates, reoperation rate, and mortality rates. Implant survival analysis was performed using Kaplan-Meier methodology with local complication as the endpoint. Binary logistical regression was performed to identify risk factors for developing local complications. The study included 227 DFRs with a median age of 78.2 years (IQR 70.1 to 84.0). Indications were periprosthetic femoral fracture (PFF) (n = 74; 33%), aseptic revision arthroplasty (n = 45; 20%), acute trauma (n = 42; 19%), infected revision arthroplasty (n = 40; 18%), chronic/failed trauma (n = 14; 6%), and complex primary arthroplasty (n = 12; 5%). Median follow-up was 3.9 years (IQR 1.5 to 7.1). RESULTS: The local complication rate was 21% (48 cases). The most common local complications were periprosthetic joint infection (n = 22; 10%), PFF (n = 7; 3%), and aseptic loosening (n = 7; 3%). Blood transfusion was required in 57 patients (25%), while 67 (30%) required critical care facilities. A return to baseline mobility and residence was observed in 94 (50%) and 183 (83%) patients, respectively. The six-month systemic complication rate was 12% (n = 27) and the reoperation rate was 16% (n = 36). The 30-day and one-year mortality rates were 3% (n = 6) and 9% (n = 21), respectively. The two-year implant survival rate was 80.9% (SE 2.8). Binary logistic regression demonstrated surgery for infected revision arthroplasty, an increasing construct:stem ratio, and increasing operating time were associated with a higher risk of failure (p < 0.05). CONCLUSION: This is the largest study of DFR for nononcological conditions. Due to high local complication and reoperation rates, it should be considered as a salvage option for complex knee reconstruction and patients should be counselled appropriately.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Wijesekera MP, Pandit H, Jain S, et al. A UK multicentre cohort study of clinical outcomes of distal femoral replacement for nononcological conditions : the EndoProsthetic Replacement for nonOncological conditions (EPRO) study. Bone Joint J. 2025. PMID: 40449544. doi:10.1302/0301-620X.107B6.BJJ-2024-1303.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。